tiprankstipranks
Adhera Therapeutics (ATRX)
OTHER OTC:ATRX
US Market
Holding ATRX?
Track your performance easily

Adhera Therapeutics (ATRX) Income Statement

12 Followers

Adhera Therapeutics Income Statement

Last quarter (Q ), Adhera Therapeutics's total revenue was $―, a decrease of ― from the same quarter last year. In Q, Adhera Therapeutics's net income was $-3.56M. See Adhera Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
----$ 252.00K$ 76.00K
Cost of Revenue
----$ 409.00K$ 284.00K
Gross Profit
----$ -157.00K$ -208.00K
Operating Expense
$ 1.28M$ 1.62M$ 674.00K$ 2.04M$ 10.04M$ 10.52M
Operating Income
$ -1.28M$ -1.62M$ -674.00K$ -2.04M$ -10.20M$ -10.73M
Net Non Operating Interest Income Expense
$ -1.41M$ 3.15M$ -1.03M$ -935.00K$ -662.00K$ -37.00K
Other Income Expense
$ -797.71K$ 2.66M$ 4.24M$ -45.00K$ -338.00K$ 810.00K
Pretax Income
$ -4.13M$ -2.11M$ -6.35M$ -3.77M$ -11.98M$ -16.75M
Tax Provision
$ -637.31K$ -637.31K$ -808.35K---
Earnings From Equity Interest Net Of Tax
$ -124.92K$ -620.00K$ -1.51M$ -1.54M--
Net Income Common Stockholders
$ -2.05M$ -2.73M$ -8.40M$ -5.31M$ -13.48M$ -17.82M
Basic EPS
$ -0.88$ -1.18$ -13.00$ -9.80$ -24.80-
Diluted EPS
$ -0.96$ -1.18$ -13.00$ -9.80$ -24.80$ -32.80
Basic Average Shares
$ 15.01M$ 2.31M$ 650.18K$ 543.83K$ 542.04K$ 541.94K
Diluted Average Shares
$ 111.23M$ 2.31M$ 650.18K$ 543.83K$ 542.04K$ 541.94K
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 13.50K$ 1.62M$ 674.00K$ 2.04M$ 10.45M$ 10.81M
Net Income From Continuing And Discontinued Operation
$ -2.75M$ -2.11M$ -6.35M$ -3.77M$ -11.98M$ -16.75M
Normalized Income
------
Interest Expense
------
EBIT
$ -1.50M$ 1.04M$ -4.92M$ -2.83M$ -11.32M$ -16.72M
EBITDA
$ -1.50M$ 1.04M$ -4.92M$ -1.99M$ -10.87M$ -16.27M
Currency in USD

Adhera Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis